Innovation in Diuretic Therapy: The Missing Ingredient for Treating Worsening Heart Failure Outside the Hospital?

por Greene, Stephen J., Felker, G. Michael
Publicado 2018

Recognizing the Significance of Outpatient Worsening Heart Failure

por Khan, Muhammad Shahzeb, Butler, Javed, Greene, Stephen J.
Publicado 2020

Prognostic Interplay Between COVID-19 and Heart Failure With Reduced Ejection Fraction

por Greene, STEPHEN J., LAUTSCH, DOMINIK, YANG, LINGFENG, TAN, XI, BRADY, JOANNE E.
Publicado 2022

Heart failure with reduced ejection fraction and the intersection of cardio-renal-metabolic medicine #CaReMe

por Marx, Nikolaus, Cheng, Alice Y Y, Agarwal, Rajiv, Greene, Stephen J, Abuhantash, Hadi
Publicado 2022

The Landscape of Cardiovascular Clinical Trials in the United States Initiated Before and During COVID‐19

por Selvaraj, Senthil, Greene, Stephen J., Khatana, Sameed Ahmed M., Nathan, Ashwin S., Solomon, Scott D., Bhatt, Deepak L.
Publicado 2020

Renin–angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta‐analysis

por Khan, Muhammad Shahzeb, Fonarow, Gregg C., Khan, Hassan, Greene, Stephen J., Anker, Stefan D., Gheorghiade, Mihai, Butler, Javed
Publicado 2017

Evaluation of Representation of Women as Authors in Pivotal Trials Supporting US Food and Drug Administration Approval of Novel Cardiovascular Drugs

por Shahid, Izza, Khan, Muhammad Shahzeb, Sohail, Aruba, Khan, Safi U., Greene, Stephen J., Fudim, Marat, Michos, Erin D.
Publicado 2022

Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction

por Barroso, Michael Coll, Kramer, Frank, Greene, Stephen J., Scheyer, Daniel, Köhler, Till, Karoff, Martin, Seyfarth, Melchior, Gheorghiade, Mihai, Dinh, Wilfried
Publicado 2016

Ten‐Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs

por Khan, Muhammad Shahzeb, Shahid, Izza, Siddiqi, Tariq Jamal, Khan, Safi U., Warraich, Haider J., Greene, Stephen J., Butler, Javed, Michos, Erin D.
Publicado 2020

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis

por Butler, Javed, Usman, Muhammad Shariq, Khan, Muhammad Shahzeb, Greene, Stephen J., Friede, Tim, Vaduganathan, Muthiah, Filippatos, Gerasimos, Coats, Andrew J. Stewart, Anker, Stefan D.
Publicado 2020

Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results

por Khan, Muhammad Shahzeb, Shahid, Izza, Asad, Nava, Greene, Stephen J., Khan, Safi U., Doukky, Rami, Metra, Marco, Anker, Stefan D., Filippatos, Gerasimos S., Fonarow, Gregg C., Butler, Javed
Publicado 2020

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018

por Salah, Husam M., Minhas, Abdul Mannan Khan, Khan, Muhammad Shahzeb, Khan, Safi U., Ambrosy, Andrew P., Blumer, Vanessa, Vaduganathan, Muthiah, Greene, Stephen J., Pandey, Ambarish, Fudim, Marat
Publicado 2022

Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

por Usman, Muhammad Shariq, Khan, Muhammad Shahzeb, Fonarow, Gregg C., Greene, Stephen J., Friede, Tim, Vaduganathan, Muthiah, Filippatos, Gerasimos, Coats, Andrew J. Stewart, Anker, Stefan D., Butler, Javed
Publicado 2022

The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction

por Greene, Stephen J., Gheorghiade, Mihai, Borlaug, Barry A., Pieske, Burkert, Vaduganathan, Muthiah, Burnett, John C., Roessig, Lothar, Stasch, Johannes‐Peter, Solomon, Scott D., Paulus, Walter J., Butler, Javed
Publicado 2013

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States

por Greene, Stephen J., Spertus, John A., Tang, Wenxi, Kang, Amiee, Zhong, Yue, Myers, Michael C., Shen, Sophie, Jiang, Jenny, Liu, Xuejun, Steffen, David R., Viola, Marta G., Felker, G. Michael
Publicado 2023

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

por Usman, Muhammad Shariq, Siddiqi, Tariq Jamal, Khan, Muhammad Shahzeb, Ahmed, Areeba, Ali, Syed Saad, Michos, Erin D., Hall, Michael E., Krasuski, Richard A., Greene, Stephen J., Butler, Javed, Alkhouli, Mohamad
Publicado 2020

Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials

por Khan, Muhammad Shahzeb, Khan, Muhammad Arbaz Arshad, Irfan, Simra, Siddiqi, Tariq Jamal, Greene, Stephen J., Anker, Stefan D., Sreenivasan, Jayakumar, Friede, Tim, Tahhan, Ayman Samman, Vaduganathan, Muthiah, Fonarow, Gregg C., Butler, Javed
Publicado 2020

Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-ana...

por Salah, Husam M., Al’Aref, Subhi J., Khan, Muhammad Shahzeb, Al-Hawwas, Malek, Vallurupalli, Srikanth, Mehta, Jawahar L., Mounsey, J. Paul, Greene, Stephen J., McGuire, Darren K., Lopes, Renato D., Fudim, Marat
Publicado 2022

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction

por Harrington, Josephine, Sun, Jie‐Lena, Fonarow, Gregg C., Heitner, Stephen B., Divanji, Punag H., Binder, Gary, Allen, Larry A., Alhanti, Brooke, Yancy, Clyde W., Albert, Nancy M., DeVore, Adam D., Felker, G. Michael, Greene, Stephen J.
Publicado 2023

Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

por Razaghizad, Amir, Oulousian, Emily, Randhawa, Varinder Kaur, Ferreira, João Pedro, Brophy, James M., Greene, Stephen J., Guida, Julian, Felker, G. Michael, Fudim, Marat, Tsoukas, Michael, Peters, Tricia M., Mavrakanas, Thomas A., Giannetti, Nadia, Ezekowitz, Justin, Sharma, Abhinav
Publicado 2022